Handelsbanken Fonder has bought 80,000 shares in blood analysis company CellaVision on 29 October.
Following the purchase, the holding amounts to 1,246,994 shares, corresponding to 5.23 percent of the capital and votes. The fund manager thereby exceeds the 5 percent disclosure threshold.
